Clinical trial
Pretreatment Haemodynamic Prediction of Recorded Early Circulatory Deterioration After Documented Short-Acting Beta-Blocker Treatment in Intensive Care: A Retrospective Multicohort Study
NCT07846995 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pretreatment Haemodynamic Prediction of Recorded Early Circulatory Deterioration After Documented Short-Acting Beta-Blocker Treatment in Intensive Care: A Retrospective Multicohort Study
- Lead sponsor
- Shanghai Zhongshan Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 1, 2026
- Completion date
- September 22, 2026
- Enrollment
- 2,541 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.